Virtual Event Coverage

33rd Annual ROTH Conference

March 15-17, 2021 - Virtual Event

ROTH Capital Partners' Annual Conference is one of the largest events of its kind in the United States. Following the success of previous ROTH conferences with 500+ companies and 5,000+ attendees attending annually, this year's event will take place in a virtual format. To ensure another successful year, InvestorBrandNetwork has provided this custom-built portal for use by all the attendees who planned to return March 15-17, 2021, as well as those who follow us via our various brands. The summaries written by our team below can be used to proficiently evaluate each of the invited companies, to gain access to our market research tools, and to easily visit any company's website that attracts interest. For more information visit

Presenting Companies: A - E F - J K - O P - Z

22nd Century Group Inc. (NYSE American: XXII)

22nd Century Group Inc. (NYSE American: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing and modern plant breeding. 22nd Century's primary mission in tobacco is to reduce the harm caused by smoking through the company's proprietary reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes. The company's primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits. For more information, visit the company's website at

A-Mark Precious Metals Inc. (NASDAQ: AMRK)

A-Mark Precious Metals Inc. (NASDAQ: AMRK) is a leading full-service precious metals trading company and wholesaler of gold, silver, platinum and palladium bullion and related products. The company's global customer base includes sovereign and private mints, manufacturers and fabricators, refiners, dealers and online retailers, financial institutions, industrial users, investors, collectors and retail customers. The company conducts its operations through three complementary segments: Wholesale Trading & Ancillary Services, Secured Lending and Direct Sales. A-Mark is headquartered in El Segundo, California, with offices and facilities in Vienna, Austria, and Las Vegas, Nevada. For more information, visit the company's website at

Acer Therapeutics Inc. (NASDAQ: ACER)

Acer Therapeutics Inc. (NASDAQ: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. Acer's pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); EDSIVOT (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms (iVMS); and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. Each of Acer's product candidates is believed to present a comparatively de-risked profile, having one or more of a favorable safety profile, clinical proof-of-concept data, mechanistic differentiation and/or accelerated paths for development through specific programs and procedures established by the FDA. For more information, visit the company's website at

ACM Research Inc. (NASDAQ: ACMR)

ACM Research Inc. (NASDAQ: ACMR) is a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications. ACM develops, manufactures, and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing and thermal processes that are critical to advanced semiconductor device manufacturing, as well as wafer-level packaging. The company is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield. For more information, visit the company's website at

AcuityAds Holdings Inc. (TSX: AT) (OTCQX: ACUIF)

AcuityAds Holdings Inc. (TSX: AT) (OTCQX: ACUIF) is a leading technology company that provides marketers a one-stop solution for omnichannel digital advertising with best-of-category return on advertising spend. Its journey automation technology, illumin, offers planning, buying and real-time intelligence from one platform. With proprietary artificial intelligence, illumin brings unique programmatic capabilities to close the gap between advertising planning and execution. The company brings an integrated ecosystem of privacy-protected data, inventory, brand safety and fraud prevention partners, offering trusted solutions with proven, above-benchmark outcomes for the most demanding marketers. AcuityAds is headquartered in Toronto with offices throughout Canada, the U.S., Europe and Latin America. For more information, visit the company's website at

Adaptimmune Therapeutics plc (NASDAQ: ADAP)

Adaptimmune Therapeutics plc (NASDAQ: ADAP) is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for people with cancer. The company's unique SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell platform enables the engineering of T-cells to target and destroy cancer across multiple solid tumors. A leader in T-cell therapy, Adaptimmune has clinical trials ongoing for three wholly owned SPEAR T-cells (ADP-A2M4, ADP-A2M4CD8, and ADP-A2AFP) in multiple solid tumor indications. The company has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. SPEAR T-cell therapies offer promise to patients that often have no other options. For more information, visit the company's website at


ADOMANI Inc. (OTCQB: ADOM) is a provider of new zero-emission electric vehicles and is a provider of zero-emission electric drivetrain systems for integration in medium to heavy-duty commercial fleet vehicles, as well as re-power conversion kits for the replacement of drivetrain systems in combustion-powered vehicles. ADOMANI's zero-emission electric vehicles are focused on reducing the total cost of vehicle ownership and help fleet operators unlock the benefits of green technology and address the challenges of traditional fuel price cost instability and local, state and federal environmental regulatory compliance. For more information, visit the company's website at

Advanced Energy Industries Inc. (NASDAQ: AEIS)

Advanced Energy Industries Inc. (NASDAQ: AEIS) is a global leader in the design and manufacturing of highly engineered, precision power conversion, measurement and control solutions for mission-critical applications and processes. AE's power solutions enable customer innovation in complex applications for a wide range of industries including semiconductor equipment, industrial, manufacturing, telecommunications, data center computing and health care. With engineering know-how and responsive service and support around the globe, the company builds collaborative partnerships to meet technology advances, propel growth for its customers and innovate the future of power. Advanced Energy has devoted more than three decades to perfecting power for its global customers and is headquartered in Denver, Colorado. For more information, visit the company's website at

Aemetis Inc. (NASDAQ: AMTX)

Aemetis Inc. (NASDAQ: AMTX) is a renewable natural gas, renewable fuel and bioproducts company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products. Founded in 2006, Aemetis has completed Phase 1 and is expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas (RNG). Aemetis owns and operates a 65 million gallon per year ethanol production facility in California's Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis also owns and operates a 50 million gallon per year production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India and Europe. For more information, visit the company's website at

Aeva/InterPrivate Acquisition Corp. (NYSE: IPV)

Aeva/InterPrivate Acquisition Corp. (NYSE: IPV) is building the next generation of sensing and perception for autonomous vehicles and beyond. Aeva is currently working with 30 of the top OEM and automotive industry players; has received strategic investments from Porsche SE, the majority shareholder of VW Group; and has partnered with some of the largest Tier 1 automotive suppliers, including a production partnership with ZF. In November 2020, Aeva entered into a definitive agreement to merge with InterPrivate Acquisition Corp (NYSE: IPV), a publicly traded special purpose acquisition company, in the first quarter of 2021. The combined company is expected to be listed on the New York Stock Exchange under ticker symbol 'AEVA'. For more information, visit the company's website at

AgEagle Aerial Systems Inc. (NYSE American: UAVS)

AgEagle Aerial Systems Inc. (NYSE American: UAVS) is one of the nation's leading commercial drone technology, services and solutions providers. AgEagle delivers the metrics, tools and strategies necessary to define and implement drone-enabled solutions that solve customer problems. AgEagle's growth strategy is focused on three pursuits: 1) Contract Manufacturing: establishing AgEagle as the dominant commercial drone design, engineering, manufacturing, assembly and testing company in the U.S.; 2) Drone Solutions: establishing AgEagle as the world's trusted source for turn-key drone delivery services and solutions; and 3) Ag Solutions: leveraging the company's reputation as one of the leading technology solutions providers to the agriculture industry with best-in-class drones and data analytics. For more information, visit the company's website at

Agilyx AS (OSL: AGLX)

Agilyx AS (OSL: AGLX) is a pioneer in the advanced recycling of difficult-to-recycle post-use plastic streams. With Agilyx's chemical recycling technology and intelligent feedstock management system, mixed plastic waste can be converted to new virgin-equivalent plastics, as well as chemical products and fuels – creating the opportunity for true circularity. The company has not only developed these first-to-market products but has also developed a feedstock management company Cyclyx International, Inc. and is working with many waste service providers, municipalities, petrochemical, and brand and retail companies to develop closed-loop advanced recycling solutions for mixed waste plastics. For more information, visit the company's website at

Agrify Corp. (NASDAQ: AGFY)

Agrify Corp. (NASDAQ: AGFY) is a developer of premium grow solutions for the indoor agriculture marketplace. The company uses data, science and technology to empower customers to be more efficient, more productive and more intelligent about how they run their businesses. Agrify's highly advanced and proprietary hardware and software solutions have been designed to help customers achieve the highest quality, consistency and yield, all at the lowest possible cost. For more information, visit the company's website at

AgroFresh Solutions Inc. (NASDAQ: AGFS)

AgroFresh Solutions Inc. (NASDAQ: AGFS) is a leading AgTech innovator and provider of science-based solutions, data-driven technologies and experience-backed services to enhance the quality and extend the shelf life of fresh produce. For more than 20 years, AgroFresh has been revolutionizing the apple industry and has launched new innovative solutions in a variety of fresh produce categories, from bananas to cherries and citrus to pears. AgroFresh supports growers, packers and retailers by providing near- and post-harvest solutions across the industry to enhance crop values while conserving the planet's resources and reducing global food waste. For more information, visit the company's website at

Airgain Inc. (NASDAQ: AIRG)

Airgain Inc. (NASDAQ: AIRG) is a leading provider of advanced antenna technologies used to enable high performance wireless networking across a broad range of devices and markets, including consumer, enterprise and automotive. Combining design-led thinking with testing and development, Airgain works in partnership with the entire ecosystem, including carriers, chipset suppliers, OEMs and ODMs. Airgain's antennas are deployed in carrier, fleet, enterprise, residential, private, government and public safety wireless networks and systems, including set-top boxes, access points, routers, modems, gateways, media adapters, portables, digital televisions, sensors, fleet and asset tracking devices. For more information, visit the company's website at

Akari Therapeutics Plc (NASDAQ: AKTX)

Akari Therapeutics Plc (NASDAQ: AKTX) is a late-stage biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation, specifically for the treatment of rare and orphan diseases, in particular those where the complement (C5) or leukotriene (LTB4) systems, or both complement and leukotrienes together, play a primary role in disease progression. Akari's lead drug candidate, nomacopan (formerly known as Coversin), is a C5 complement inhibitor that also independently and specifically inhibits leukotriene B4 (LTB4) activity. For more information, visit the company's website at

Akoustis Technologies Inc. (NASDAQ: AKTS)

Akoustis Technologies Inc. (NASDAQ: AKTS) is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters – targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The company utilizes its proprietary XBAW manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of high-purity, single-crystal and associated piezoelectric materials and the resonator-filter process technology which drives electro-mechanical coupling and translates to wide filter bandwidth. For more information, visit the company's website at Holdings Inc. (NASDAQ: ALRM) Holdings Inc. (NASDAQ: ALRM) is a leading platform for the intelligently connected property. Millions of consumers and businesses depend on's technology to manage and control their property from anywhere. The company's platform integrates with a growing variety of Internet of Things (IoT) devices through apps and interfaces.'s security, video, access control, intelligent automation, energy management, and wellness solutions are available through the company's network of thousands of professional service providers in North America and around the globe. For more information, visit the company's website at

Alico Inc. (NASDAQ: ALCO)

Alico Inc. (NASDAQ: ALCO) is an agribusiness company with a legacy of achievement and innovation in citrus and conservation. The company owns approximately 103,000 acres of land across eight Florida counties. The current principal lines of business are citrus groves and land conservation/leasing. Alico, Inc. primarily operates two divisions: Alico Citrus, one of the nation's largest citrus producers, and Alico Land Management and Other Operations, which include environmental services, land leasing and related support operations. For more information, visit the company's website at

Allied Motion Technologies Inc. (NASDAQ: AMOT)

Allied Motion Technologies Inc. (NASDAQ: AMOT) designs, manufactures and sells precision and specialty-controlled motion products and solutions used in a broad range of industries within major served markets, which include vehicle, medical, aerospace and defense, and industrial. Headquartered in Amherst, NY, the company has global operations and sells into markets across the United States, Canada, South America, Europe and Asia. The company's growth strategy is focused on being the controlled motion solutions leader in its selected target markets by leveraging its "technology/know how" to develop integrated precision solutions that utilize multiple Allied Motion technologies to "change the game" and create higher value solutions for its customers. For more information, visit the company's website at

Allogene Therapeutics Inc. (NASDAQ: ALLO)

Allogene Therapeutics Inc. (NASDAQ: ALLO) is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) therapies for cancer. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of "off-the-shelf" CAR T cell therapy candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. For more information, visit the company's website at

Ambarella Inc. (NASDAQ: AMBA)

Ambarella Inc. (NASDAQ: AMBA) is an AI vision silicon company. Ambarella's products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving, and robotic applications. Ambarella's low-power system on chips (SoCs) offer high-resolution video compression, advanced image processing, and powerful deep neural network processing to enable intelligent cameras to extract valuable data from high-resolution video streams. For more information, visit the company's website at

Ameresco Inc. (NYSE: AMRC)

Ameresco Inc. (NYSE: AMRC) is a leading independent clean technology integrator of comprehensive services, energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions for businesses and organizations throughout North America and Europe. Ameresco's sustainability services include upgrades to a facility's energy infrastructure and the development, construction and operation of renewable energy plants. Ameresco has successfully completed energy saving, environmentally responsible projects with Federal, state and local governments, healthcare and educational institutions, housing authorities, and commercial and industrial customers. With its corporate headquarters in Framingham, MA, Ameresco has more than 1,000 employees providing local expertise in the United States, Canada, and the United Kingdom. For more information, visit the company's website at

American Superconductor Corp. (NASDAQ: AMSC)

American Superconductor Corp. (NASDAQ: AMSC) generates the ideas, technologies and solutions that meet the world's demand for smarter, cleaner, better energy. AMSC provides the engineering planning services and advanced grid systems that optimize network reliability, efficiency and performance. Through its Marinetec Solutions, AMSC provides ship protection systems and is developing propulsion and power management solutions designed to help fleets increase system efficiencies, enhance power quality and boost operational safety. Through its Windtec Solutions, AMSC provides wind turbine electronic controls and systems, designs and engineering services that reduce the cost of wind energy. The company's solutions are enhancing the performance and reliability of power networks, increasing the operational safety of navy fleets, and powering gigawatts of renewable energy globally. For more information, visit the company's website at

American Vanguard Corp. (NYSE: AVD)

American Vanguard Corp. (NYSE: AVD) is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® & Russell 3000® Indexes and the Standard & Poors Small Cap 600 Index. For more information, visit the company's website at


AMMO Inc. (NASDAQ: POWW) was founded in 2016 with a vision to change, innovate and invigorate the complacent munitions industry. The company designs and manufactures products for a variety of markets, including law enforcement, military, hunting, sport shooting and self-defense. AMMO promotes its company-branded munitions, its patented STREAK Visual Ammunition, stelTH subsonic munitions and O.W.L. Technologies. The company's corporate offices are headquartered in Scottsdale, Arizona. Manufacturing operations are based in both northern Arizona and Manitowoc, Wisconsin. For more information, visit the company's website at

Ampio Pharmaceuticals Inc. (NYSE American: AMPE)

Ampio Pharmaceuticals Inc. (NYSE American: AMPE) is an innovative drug discovery and development company combining scientific, clinical, and manufacturing capabilities to develop novel immunology-based therapies aimed at treating prevalent inflammatory conditions for which limited treatment options exist. Ampio's therapeutic product pipeline is the result of more than two decades of research at leading hospital-based research centers. Ampio's lead drug, Ampion, is backed by an extensive patent portfolio with intellectual property protection extending through 2032 and will be eligible for 12-year FDA market exclusivity upon approval as a novel biologic under the biologics price competition and innovation act (BPCIA). For more information, visit the company's website at

Amplify Energy Corp. (NYSE: AMPY)

Amplify Energy Corp. (NYSE: AMPY) is an independent oil and natural gas company engaged in the acquisition, development, exploration and production of oil and natural gas properties. The company's properties primarily consist of operated working interests in producing and undeveloped leasehold acreage and in identified producing wells in North America. Amplify's operations are focused in Oklahoma, the Rockies, offshore California, East Texas / North Louisiana and South Texas. The company also owns non-operated working interests in producing and undeveloped leasehold acreage. For more information, visit the company's website at

Amtech Systems Inc. (NASDAQ: ASYS)

Amtech Systems Inc. (NASDAQ: ASYS) is a leading, global manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power devices, analog and discrete devices, electronic assemblies and light-emitting diodes (LEDs). Amtech sells these products to semiconductor device and module manufacturers worldwide, particularly in Asia, North America and Europe. The company's strategic focus is on semiconductor growth opportunities in power electronics, sensors and analog devices, leveraging its strength in its core competencies in thermal and substrate processing. Amtech is a market leader in the high-end power chip market (SiC substrates, 300mm horizontal thermal reactor, and electronic assemblies used in power, RF, and other advanced applications), developing and supplying essential equipment and consumables used in the semiconductor industry. For more information, visit the company's website at

Anterix Inc. (NASDAQ: ATEX)

Anterix Inc. (NASDAQ: ATEX) is focused on delivering transformative private broadband that enables the modernization of critical infrastructure for the energy, transportation, logistics and other sectors of the economy. As the largest holder of licensed spectrum in the 900 MHz band, with nationwide coverage throughout the contiguous United States, Hawaii, Alaska and Puerto Rico, the company is uniquely positioned to enable the private LTE solutions that support secure, resilient and customer-controlled operations. For more information, visit the company's website at

Antibe Therapeutics Inc. (TSX: ATE) (OTCQX: ATBPF)

Antibe Therapeutics Inc. (TSX: ATE) (OTCQX: ATBPF) is a biotechnology company exploiting groundbreaking advances in inflammation science. Antibe is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to address inflammation arising from a wide range of medical conditions. Antibe's current pipeline includes three assets that seek to overcome the gastrointestinal ("GI") ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs ("NSAIDs"). Antibe's lead drug, otenaproxesul (formerly ATB-346), is entering Phase III for osteoarthritis pain. Additional assets under development include a safer alternative to opioids for peri-operative pain, and a GI-safe alternative to low-dose aspirin. The company's next target is inflammatory bowel disease ("IBD"), a condition long in need of safer, more effective therapies. For more information, visit the company's website at

Apellis Pharmaceuticals Inc. (NASDAQ: APLS)

Apellis Pharmaceuticals Inc. (NASDAQ: APLS) is a global biopharmaceutical company that is committed to leveraging courageous science, creativity and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, Apellis aims to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, visit the company's website at

AppHarvest Inc. (NASDAQ: APPH)

AppHarvest Inc. (NASDAQ: APPH) is an applied technology company building some of the world's largest indoor farms in Appalachia. The company combines conventional agricultural techniques with cutting-edge technology and is addressing key issues including improving access for all to nutritious food, farming more sustainably, building a home-grown food supply, and increasing investment in Appalachia. The company operates some of the country's largest high-tech indoor farms to sustainably grow affordable, nutritious, chemical pesticide-free non-GMO fruits and vegetables at scale using 90 percent less water than traditional open-field agriculture and 100 percent recycled rainwater. AppHarvest recently went public via a SPAC merger with Novus Capital Corporation. For more information, visit the company's website at

Applied DNA Sciences Inc. (NASDAQ: APDN)

Applied DNA Sciences Inc. (NASDAQ: APDN) is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates. For more information, visit the company's website at

Applied Genetic Technologies Corp. (NASDAQ: AGTC)

Applied Genetic Technologies Corp. (NASDAQ: AGTC) ) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company's industry-leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. For more information, visit the company's website at

Aptevo Therapeutics Inc. (NASDAQ: APVO)

Aptevo Therapeutics Inc. (NASDAQ: APVO) is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The company's lead clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed based on the company's versatile and robust ADAPTIR modular protein platform technology. APVO442 was developed based on the new ADAPTIR-FLEX platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating highly differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. For more information, visit the company's website at

Arcimoto Inc. (NASDAQ: FUV)

Arcimoto Inc. (NASDAQ: FUV) develops and manufactures ultra-efficient and affordable electric vehicles to help the world shift to a sustainable transportation system. Now available to preorder customers in California, Oregon, Washington and Florida, the Arcimoto FUV® is purpose-built for everyday driving, transforming ordinary trips into pure-electric joyrides. Available for preorder, the Deliverator® and Rapid Responder™ provide last-mile delivery and emergency response functionality, respectively, at a fraction of the cost and environmental impact of traditional gas-powered vehicles. Two additional concept prototypes built on the versatile Arcimoto platform are currently in development: the Cameo™, aimed at the film and influencer industry, and the Roadster, designed to be the ultimate on-road fun machine. Every Arcimoto vehicle is built at the Arcimoto Manufacturing Plant in Eugene, Oregon. For more information, visit the company's website at

Aridis Pharmaceuticals Inc. (NASDAQ: ARDS)

Aridis Pharmaceuticals Inc. (NASDAQ: ARDS) is a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections. Aridis discovers and develops anti-infectives to be used as add-on treatments to standard-of-care antibiotics. The company is utilizing its proprietary ʎPEX and MabIgX technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) for therapeutic treatment of critical infections. These mAbs are already of human origin and functionally optimized for high potency by the donor's immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality. For more information, visit the company's website at

Array Technologies Inc. (NASDAQ: ARRY)

Array Technologies Inc. (NASDAQ: ARRY) is a leading global technology company providing tracker solutions and services for utility-scale solar energy projects as one of the world's largest manufacturers of ground-mounting systems. With efficient installation and terrain flexibility coupled with high reliability, durability, and performance, Array delivers a lower levelized cost of energy. The company's focus on innovation, combined with its customer-centric approach, has helped achieve some of the industry's best returns. Array Technologies is headquartered in the United States with offices in Europe, Central America, and Australia. For more information, visit the company's website at

Arvinas Inc. (NASDAQ: ARVN)

Arvinas Inc. (NASDAQ: ARVN) is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC® protein degraders against validated and "undruggable" targets, the company has two clinical-stage programs: ARV-110 for the treatment of men with metastatic castrate-resistant prostate cancer; and ARV-471 for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer. For more information, visit the company's website at

Ascot Resources Ltd. (TSX: AOT) (OTCQX: AOTVF)

Ascot Resources Ltd. (TSX: AOT) (OTCQX: AOTVF) is a Canadian-based exploration and development company focused on re-starting the past producing historic Premier gold mine, located in British Columbia's Golden Triangle. The company continues to define high-grade resources for underground mining with the near-term goal of converting the underground resources into reserves, while continuing to explore nearby targets on its Premier/Dilworth and Silver Coin properties (collectively referred to as the Premier Gold Project). Ascot's acquisition of IDM Mining added the high-grade gold and silver, Red Mountain Project to its portfolio and positions the company as a leading consolidator of high-quality assets in the Golden Triangle. For more information, visit the company's website at

Aspen Group Inc. (NASDAQ: ASPU)

Aspen Group Inc. (NASDAQ: ASPU) is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again. For more information, visit the company's website at

Assertio Holdings Inc. (NASDAQ: ASRT)

Assertio Holdings, Inc. (NASDAQ: ASRT) is a leading commercial pharmaceutical company bringing differentiated products to patients. The company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. Assertio has grown through business development including licensing, mergers and acquisitions. For more information, visit the company's website at

Assure Holdings Corp. (TSX.V: IOM) (OTCQB: ARHH)

Assure Holdings Corp. (TSXV: IOM) (OTCQB: ARHH) is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned The Joint Commission's Gold Seal of Approval. For more information, visit the company's website at

Asure Software Inc. (NASDAQ: ASUR)

Asure Software Inc. (NASDAQ: ASUR) sees human capital management (HCM) through the lens of entrepreneurs and executives with an owner's mentality. Asure's clients include more than 60,000 small and mid-sized businesses, helping each to develop their "human capital" to get to the next level, stay compliant and allocate their time, money and technology toward growth. Asure's HCM solution includes Asure Payroll and Tax, Asure HR and Asure Time and Attendance. The company's Asure HRServices offer ranges from online compliance tools to a fully outsourced HR department. For more information, visit the company's website at

Atara Biotherapeutics Inc. (NASDAQ: ATRA)

Atara Biotherapeutics Inc. (NASDAQ: ATRA) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With its lead program in Phase 3 clinical development, Atara intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. The company's platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform to create a robust pipeline of therapeutics. For more information, visit the company's website at

Atreca Inc. (NASDAQ: BCEL)

Atreca Inc. (NASDAQ: BCEL) is a biotechnology company developing novel therapeutics drawn from human immune responses, including effective anti-cancer immune responses. Atreca is able to measure and analyze the structure of clinically relevant immune responses to identify the antibodies, T cell receptors, and targets that are key to successful treatment outcomes. The company's proprietary Immune Repertoire Capture technology profiles a patient's immune response at the single-cell level at very high throughput essentially without bias or error, enabling the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen. The company is advancing a pipeline of candidates designed to engage the human immune response in oncology and other indications, thus driving better therapeutic outcomes. For more information, visit the company's website at

aTyr Pharma Inc. (NASDAQ: LIFE)

aTyr Pharma Inc. (NASDAQ: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr's research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr's primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in inflammatory lung diseases. For more information, visit the company's website at

Avalon GloboCare Corp. (NASDAQ: AVCO)

Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics. For more information, visit the company's website at

Aviat Networks Inc. (NASDAQ: AVNW)

Aviat Networks Inc. (NASDAQ: AVNW) is a leading expert in wireless transport solutions and works to provide dependable products, services and support to its customers. With more than one million systems sold into 170 countries worldwide, communications service providers and private network operators including state/local government, utility, federal government and defense organizations trust Aviat with their critical applications. Coupled with a long history of microwave innovations, Aviat provides a comprehensive suite of localized professional and support services enabling customers to drastically simplify both their networks and their lives. For more than 70 years, the experts at Aviat have delivered high-performance products, simplified operations, and the best overall customer experience. For more information, visit the company's website at

Avid Technology Inc. (NASDAQ: AVID)

Avid Technology Inc. (NASDAQ: AVID) delivers some of the most open and efficient media platforms, connecting content creation with collaboration, asset protection, distribution, and consumption. Avid's preeminent customer community uses Avid's comprehensive tools and workflow solutions to create, distribute and monetize the most watched, loved and listened to media in the world—from prestigious and award-winning feature films to popular television shows, news programs and televised sporting events, and celebrated music recordings and live concerts. With the most flexible deployment and pricing options, Avid's industry-leading solutions include Media Composer, Pro Tools, Avid NEXIS, MediaCentral, iNEWS, AirSpeed, Sibelius, Avid VENUE, FastServe, and Maestro. For more information, visit the company's website at

Axcella Health Inc. (NASDAQ: AXLA)

Axcella Health Inc. (NASDAQ: AXLA) is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health. The company's product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. Axcella's pipeline includes lead therapeutic candidates for non-alcoholic steatohepatitis (NASH) and the prevention of recurrent overt hepatic encephalopathy (OHE). Additional muscle- and blood-related programs are in earlier-stage development. For more information, visit the company's website at

Ayala Pharmaceuticals Inc. (NASDAQ: AYLA)

Ayala Pharmaceuticals Inc. (NASDAQ: AYLA) is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayala's approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next generation sequencing to deliver targeted therapies to underserved patient populations. The company has two product candidates under development, AL101 and AL102, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors. Ayala's lead product candidate, AL101, has received Fast Track Designation and Orphan Drug Designation from the U.S. FDA and is currently in a Phase 2 clinical trial. For more information, visit the company's website at

Ayr Strategies Inc. (CSE: AYR.A) (OTCQX: AYRWF)

Ayr Strategies Inc. (CSE: AYR.A) (OTCQX: AYRWF) s an expanding vertically integrated, U.S. multi-state cannabis operator, focusing on high-growth markets. The company cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and through third-party stores. Ayr strives to enrich consumers' experience every day – helping them to live their best lives, elevated. Ayr's leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they touch. For more information, visit the company's website at

Azure Power Global Ltd. (NYSE: AZRE)

Azure Power Global Ltd. (NYSE: AZRE) is a leading independent solar power producer with a pan-India portfolio of 7.1 gigawatts on September 30, 2020 of which 1.8 GWs is operational, 1.3 GWs are under construction and 4.0 GWs have received a Letter of Award but for which PPAs have yet to be signed. Azure Power developed India's first private utility scale solar project in 2009 and has been at the forefront in the sector as a developer and operator of solar projects since its inception in 2008. With its in-house engineering, procurement and construction expertise and advanced in-house operations and maintenance capability, Azure Power manages the entire development and operation process, providing low-cost solar power solutions to customers throughout India. For more information, visit the company's website at

AzurRx BioPharma Inc. (NASDAQ: AZRX)

AzurRx BioPharma Inc. (NASDAQ: AZRX) is a biopharmaceutical company specializing in the research and development of non-systemic biologics for gastrointestinal disorders. The company is focused on the development of its lead drug candidate, MS1819. AzurRx is currently conducting two Phase 2 clinical trials of MS1819: the OPTION 2 monotherapy trial and the Combination therapy trial, consisting of MS1819 in conjunction with porcine-derived pancreatic enzyme replacement therapy, the current standard of care. AzurRx is headquartered in New York with scientific operations based in Langlade, France, and clinical operations in Hayward, California. For more information, visit the company's website at

Babcock & Wilcox Enterprises Inc. (NYSE: BW)

Babcock & Wilcox Enterprises Inc. (NYSE: BW) is a global leader in energy and environmental technologies and services for the power and industrial markets. The company is built and sustained by employees with curious minds and persevering wills. Babcock & Wilcox works hard to earn the trust of its customers and deliver value with the highest level of ethics and integrity. The year 2017 marked the 150th anniversary of Babcock & Wilcox, the company that began in 1867 with one patent, two friends and an unwavering commitment to reliable and effective innovation. For more information, visit the company's website at

Ballard Power Systems Inc. (NASDAQ: BLDP) (TSX: BLDP)

Ballard Power Systems Inc. (NASDAQ: BLDP) (TSX: BLDP) aims to deliver fuel cell power for a sustainable planet. Ballard zero-emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars and forklift trucks. For more information, visit the company's website at

Barkbox/ Northern Star Acquisition Corp (NYSE: STIC)

Barkbox/ Northern Star Acquisition Corp (NYSE: STIC) is a leading global brand for dogs, devoted to making dogs happy with the best products, services and content. Northern Star Acquisition Corp. is a special purpose acquisition company. The two have entered into a definitive merger agreement. As a result of the transaction, which values the company at an enterprise value of approximately $1.6 billion, BARK will become a publicly listed company on the New York Stock Exchange under new ticker symbol 'BARK'. BARK's dog-obsessed team applies its unique, data-driven understanding of what makes each dog special to design playstyle-specific toys, wildly satisfying treats and wellness supplements, and dog-first experiences that foster the health and happiness of dogs everywhere. For more information, visit the company's website at

Barrett Business Services Inc. (NASDAQ: BBSI)

Barrett Business Services Inc. (NASDAQ: BBSI) is a leading provider of business management solutions, combining human resource outsourcing and professional management consulting to create a unique operational platform that differentiates it from competitors. The company's integrated platform is built upon expertise in payroll processing, employee benefits, workers' compensation coverage, risk management and workplace safety programs, and human resource administration. BBSI's partnerships help businesses of all sizes improve the efficiency of their operations. The company works with more than 7,200 clients across all lines of business in 31 states. For more information, visit the company's website at


BBTV Holdings Inc. (TSX: BBTV) (OTCQX: BBTVF) is a media and technology company headquartered in Vancouver, Canada. The company's mission is to democratize content by leveraging its proprietary technologies to drive viewership and monetization for content creators of all sizes. From individual content creators to global media companies, BBTV monetizes the media of content creators through end-to-end management, distribution and monetization solutions, powered by its innovative VISO Platform, including related proprietary technology, while allowing content creators to focus on their core competency – content creation. In August 2020, BBTV had the second most unique monthly viewers among digital platforms with more than 600 million globally, who consumed more than 50 billion minutes of video content, the most among media companies. For more information, visit the company's website at

Beam Global (NASDAQ: BEEM)

Beam Global (NASDAQ: BEEM) is a cleantech leader that produces innovative, sustainable technology for electric vehicle (EV) charging, outdoor media and energy security, without the construction, disruption, risks and costs of grid-tied solutions. Its products include the patented EV ARC and Solar Tree lines with BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media and disaster preparedness packages. The company develops, patents, designs, engineers and manufactures unique and advanced renewably energized products that save customers time and money, help the environment, empower communities and keep people moving. For more information, visit the company's website at

BellRock Brands Inc. (CSE: BRCK.U) (OTC: DXBRF)

BellRock Brands Inc. (CSE: BRCK.U) (OTC: DXBRF) works every day with a passion to help improve the lives of people through cannabis. The company's guiding light is having a deep commitment to creating quality products that provide a consistent and safe experience for everyone. BellRock Brands is a premium house of brands, built on the pillars of trust, efficacy and a higher standard. With 10+ years and a robust portfolio of more than 200 products designed for every occasion, every need, and every person, and with unmatched scientific leadership, BellRock Brands is leading the way. For more information, visit the company's website at

Beyond Air Inc. (NASDAQ: XAIR)

Beyond Air Inc. (NASDAQ: XAIR) is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System, LungFit, that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. The company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary LungFit for clinical trials for the treatment of severe lung infections such as SARS-CoV-2 and nontuberculous mycobacteria (NTM). Additionally, Beyond Air is using ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting. For more information, visit the company's website at


BGSF Inc. (NYSE: BGSF) provides workforce solutions to a variety of industries through its various divisions in IT, cyber, finance & accounting, creative, real estate (apartment communities and commercial buildings) and light industrial. BGSF has integrated several regional and national brands achieving scalable growth. The company was ranked by Staffing Industry Analysts as the 70th largest U.S. staffing company and the 50th largest IT staffing firm in the 2020 updates. The company's disciplined acquisition philosophy, which builds value through both financial growth and the retention of unique and dedicated talent within BGSF's family of companies, has resulted in a seasoned management team with strong tenure and the ability to offer exceptional service to our field talent and client partners while building value for investors. For more information, visit the company's website at

Bio-Path Holdings Inc. (NASDAQ: BPTH)

Bio-Path Holdings Inc. (NASDAQ: BPTH) is a biotechnology company developing DNAbilize®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Path's lead product candidate, prexigebersen (BP1001, targeting the Grb2 protein), is in a Phase 2 study for blood cancers, and prexigebersen-A, a drug product modification of prexigebersen, is under consideration by the FDA to commence Phase 1 studies in solid tumors. This is followed by BP1002, targeting the Bcl-2 protein, where it is being evaluated in lymphoma clinical studies. For more information, visit the company's website at

Biocept Inc. (NASDAQ: BIOC)

Biocept Inc. (NASDAQ: BIOC) develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers, including metastatic tumors involving lung, breast and the central nervous system. Biocept's patented Target Selector™ technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) with higher sensitivity and specificity than most commercial assays. Additionally, Biocept is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 PCR testing to support public health efforts during this unprecedented pandemic. For more information, visit the company's website at

Bioceres Crop Solutions Corp. (NYSE American: BIOX)

Bioceres Crop Solutions Corp. (NYSE American: BIOX) is a fully integrated global provider of crop productivity technologies designed to enable the transition of agriculture toward carbon neutrality. The company's solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the company is bringing digital solutions to support growers' decisions and provide end-to-end traceability for production outputs. For more information, visit the company's website at

BioDelivery Sciences International Inc. (NASDAQ: BDSI)

BioDelivery Sciences International Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation. For more information, visit the company's website at

BioSig Technologies Inc. (NASDAQ: BSGM)

BioSig Technologies Inc. (NASDAQ: BSGM) is a medical device company commercializing a proprietary technology platform designed to improve the $4 billion electrophysiology (EP) marketplace. BioSig's biomedical signal processing platform is designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The company's first trademarked product, PURE EP System, is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in EP laboratories. For more information, visit the company's website at

Blackstone Minerals Ltd. (OTCQX: BLSTF)

Blackstone Minerals Ltd. (OTCQX: BLSTF) is developing the district scale Ta Khoa Project in Northern Vietnam, where the company is drilling out the large-scale Ban Phuc Nickel-Cu-PGE deposit. The Ta Khoa Nickel-Cu-PGE Project has existing modern mine infrastructure built to international standards, including a 450ktpa processing plant and permitted mine facilities. Blackstone also owns a large land holding at the Gold Bridge project within the BC porphyry belt in British Columbia, Canada, with large scale drill targets prospective for high grade gold-cobalt-copper mineralization. In Australia, Blackstone is exploring for nickel and gold in the Eastern Goldfields and gold in the Pilbara region of Western Australia. Blackstone has a board and management team with a proven track record of mineral discovery and corporate success. For more information, visit the company's website at

Blink Charging Co. (NASDAQ: BLNK)

Blink Charging Co. (NASDAQ: BLNK) is a leading owner, operator and provider of electric vehicle (EV) charging equipment and services. Blink Charging has deployed over 23,000 charging stations, many of which are networked EV charging stations, enabling EV drivers to easily charge at any of the company's charging locations worldwide. Blink Charging's principal line of products and services includes its Blink EV charging network ("Blink Network"), EV charging equipment and EV charging services. The Blink Network uses proprietary, cloud-based software that operates, maintains and tracks the EV charging stations connected to the network and the associated charging data. With global EV purchases forecast to rise to 10 million vehicles by 2025 from approximately 2 million in 2019, the company has established key strategic partnerships for rolling out adoption across numerous locations. For more information, visit the company's website at

Blue Bird Corp. (NASDAQ: BLBD)

Blue Bird Corp. (NASDAQ: BLBD) offers a complete line of Type A, C and D school buses in a variety of options and configurations. Since 1927, Blue Bird Corporation has continued to set industry standards with its innovative design and manufacturing capabilities. Additionally, Blue Bird provides comprehensive financial solutions through Blue Bird Capital Services. Today, Blue Bird has more than 1,600 employees, Georgia-based manufacturing facilities, and an extensive network of dealers, parts and service facilities throughout North America. For more information, visit the company's website at

Boingo Wireless Inc. (NASDAQ: WIFI)

Boingo Wireless Inc. (NASDAQ: WIFI) helps the world stay connected. Boingo's vast footprint of DAS, Wi-Fi and small cells reaches more than a billion people annually, making Boingo one of the largest providers of indoor wireless networks. Boingo connects people and things at airports, stadiums, military bases, convention centers, multifamily communities and commercial properties. For more information, visit the company's website at

Boqii Holding Ltd. (NYSE: BQ)

Boqii Holding Ltd. (NYSE: BQ) is China's leading pet-focused platform. Boqii is the leading destination for pet products and supplies in China with its broad selection of high-quality products including global leading brands, local emerging brands, and Boqii private labels, offered at competitive prices. Boqii's online sales platforms, including Boqii Mall and its flagship stores on third-party e-commerce platforms, provide customers with convenient access to a wide selection of high-quality pet products and an engaging and personalized shopping experience. For more information, visit the company's website at

Broadwind Inc. (NASDAQ: BWEN)

Broadwind Inc. (NASDAQ: BWEN) is a precision manufacturer of structures, equipment and components for clean tech and other specialized applications. With facilities throughout the U.S., Broadwind Energy's talented team is committed to helping customers maximize performance of their investments – quicker, easier and smarter. For more information, visit the company's website at

Burcon NutraScience Corp. (TSX: BU) (OTCQB: BUROF)

Burcon NutraScience Corp. (TSX: BU) (OTCQB: BUROF) is a global technology leader in the development of plant-based proteins. With over 300 issued patents and more than 230 additional patent applications that have been developed over a span of more than twenty years, Burcon has grown an extensive portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation was established in a joint venture by Burcon and three veteran food industry executives. Merit Foods has built a state-of-the-art protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients. For more information, visit the company's website at

BurgerFi International Inc. (NASDAQ: BFI)

BurgerFi International Inc. (NASDAQ: BFI) is among the nation's fastest-growing better burger concepts with approximately 125 restaurants domestically and internationally. The concept is chef-founded and is committed to serving fresh food of transparent quality. BurgerFi uses 100% natural American angus beef with no steroids, antibiotics, growth hormones, chemicals or additives. BurgerFi was named QSR Magazine's Breakout Brand of 2020, placed in the top 10 on Fast Casual's Top 100 Movers & Shakers list in 2020, was named "Best Burger Joint" by Consumer Reports and fellow public interest organizations in the 2019 Chain Reaction Study, listed as a "Top Restaurant Brand to Watch" by Nation's Restaurant News in 2019. For more information, visit the company's website at

Caesars Entertainment Inc. (NASDAQ: CZR)

Caesars Entertainment Inc. (NASDAQ: CZR) is the largest casino-entertainment company in the U.S. and one of the world's most diversified casino-entertainment providers. Since its beginning in Reno, Nevada, in 1937, Caesars Entertainment has grown through development of new resorts, expansions and acquisitions. Caesars Entertainment's resorts operate primarily under the Caesars®, Harrah's®, Horseshoe® and Eldorado® brand names. Caesars Entertainment offers diversified amenities and one-of-a-kind destinations, with a focus on building loyalty and value with its guests through a unique combination of impeccable service, operational excellence and technology leadership. For more information, visit the company's website at

Calavo Growers Inc. (NASDAQ: CVGW)

Calavo Growers Inc. (NASDAQ: CVGW) is a global avocado-industry leader and an expanding provider of value-added fresh food serving retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers worldwide. The company's Fresh segment procures and markets fresh avocados and other select fresh produce, including tomatoes and papayas. The Renaissance Food Group (RFG) segment creates, markets and distributes a portfolio of healthy, fresh foods, including fresh-cut fruit, fresh-cut vegetables and prepared foods. The Foods segment manufactures and distributes guacamole and salsa. Founded in 1924, Calavo's fresh food products are sold under the respected Calavo brand name as well as Garden Highway, Chef Essentials and a variety of private label and store brands. For more information, visit the company's website at

Calyxt Inc. (NASDAQ: CLXT)

Calyxt Inc. (NASDAQ: CLXT) is a plant-based technology company headquartered in Roseville, Minnesota. The company innovates, together with like-minded partners, to deliver plant-based products with wellness and sustainability benefits. Calyxt uses cutting edge plant breeding techniques to innovate and develop solutions to address unmet consumer and market demands. Calyxt accelerates the process of breeding stronger, more sustainable, higher-yielding plants with an advanced breeding technology (Transcription Activator-Like Effector Nuclease, or TALEN) that allows for precision targeting of existing genes within a plant's genome to develop better-tasting plant proteins and increase speed to market. For more information, visit the company's website at

Cambium Networks Corp. (NASDAQ: CMBM)

Cambium Networks Corp. (NASDAQ: CMBM) is a leading global provider of wireless connectivity solutions that strengthen connections between people, places, and things. Specializing in providing an end-to-end wireless fabric of reliable, scalable, secure, cloud-managed platforms that perform under demanding conditions, Cambium Networks empowers service providers and enterprise, industrial and government network operators to build intelligent edge connectivity. Headquartered outside Chicago and with R&D centers in the U.S., U.K. and India, Cambium Networks sells through a range of trusted global distributors. For more information, visit the company's website at

Canadian Solar Inc. (NASDAQ: CSIQ)

Canadian Solar Inc. (NASDAQ: CSIQ) was founded in 2001 in Canada and is one of the world's largest and foremost solar power companies. It is a leading manufacturer of solar photovoltaic modules and provider of solar energy solutions and has a geographically diversified pipeline of utility-scale power projects in various stages of development. Over the past 18 years, Canadian Solar has successfully delivered over 38 GW of premium quality modules to customers in over 150 countries around the world. Canadian Solar is one of the most bankable companies in the solar industry, having been publicly listed on Nasdaq since 2006. For more information, visit the company's website at

Cancer Genetics Inc. (NASDAQ: CGIX)

Cancer Genetics Inc. (NASDAQ: CGIX) offers proprietary preclinical test systems supporting clinical diagnostic offerings at early stages, valued by the pharmaceutical industry, biotechnology companies and academic research centers. The company is focused on precision and translational medicine to drive drug discovery and novel therapies. vivo Pharm specializes in conducting studies tailored to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro and in vivo data and reports, as needed for Investigational New Drug filings. vivo Pharm operates in The Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) accredited and GLP compliant audited facilities. For more information, visit the company's website at

Canoo, Inc. (NASDAQ: GOEV)

Canoo, Inc. (NASDAQ: GOEV) is a Los Angeles-based company that has developed breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design that put customers first and pioneering technologies. Distinguished by its experienced team - totaling over 350 employees from leading technology and automotive companies - Canoo has designed a modular electric platform purpose-built to deliver maximum vehicle interior space that is adaptable to support a wide range of vehicle applications for customers and businesses. For more information, visit the company's website at

Capstone Turbine Corp. (NASDAQ: CPST)

Capstone Turbine Corp. (NASDAQ: CPST) is the world's leading producer of highly efficient, low-emission, resilient microturbine energy systems. Capstone microturbines serve multiple vertical markets worldwide, including natural resources, energy efficiency, renewable energy, critical power supply, transportation and microgrids. Capstone offers a comprehensive product lineup via its direct sales team, as well as its global distribution network. Capstone provides scalable solutions from 30 kW to 10 MW that operate on a variety of fuels and are the ideal solution for today's multi-technology distributed power generation projects. To date, Capstone has shipped nearly 10,000 units to 83 countries; in FY20, the company saved customers an estimated $219 million in annual energy costs and 368,000 tons of carbon. For customers with limited capital or short-term needs, Capstone offers rental systems. For more information, visit the company's website at

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF)

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is a clinical-stage biotechnology company focused on the research and clinical development of innovative anti-inflammatory therapies for the treatment of cardiovascular disease ("CVD"). The company's lead product, CardiolRx™, is a pharmaceutically produced oral cannabidiol formulation that is currently entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus. This potentially registrational trial is designed to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce mortality and major cardiovascular events in COVID-19 patients who have a prior history of, or risk factors for, CVD, and to investigate the influence CardiolRx has on key markers of inflammatory heart disease. For more information, visit the company's website at Inc. (NASDAQ: PRTS) Inc. (NASDAQ: PRTS) has been a leader in the e-commerce automotive aftermarket. With over 50 million parts delivered, has helped everyday drivers across the contiguous United States find the right parts to keep their vehicles on the road. With a focus on the end-to-end customer experience, designed its website and sourcing network to simplify the way drivers get the parts they need. Combined with a 90-day return policy and satisfaction guarantee, makes it simple for customers to get parts delivered. is headquartered in Torrance, California. For more information, visit the company's website at

Carriage Services Inc. (NYSE: CSV)

Carriage Services Inc. (NYSE: CSV) is a leading provider of funeral and cemetery services and merchandise in the United States. Carriage operates 180 funeral homes in 27 states and 32 cemeteries in 12 states. Carriage provides a complete range of services relating to funerals, burials and cremations, including the use of funeral homes and motor vehicles, the performance of cemetery interment services and the management and maintenance of cemetery grounds. The company sells related products and merchandise including caskets, burial vaults, garments, cemetery interment rights, stone and bronze memorials, as well as other items. For more information, visit the company's website at

Casper Sleep Inc. (NYSE: CSPR)

Casper Sleep Inc. (NYSE: CSPR) believes everyone should sleep better. The Sleep Company has a full portfolio of obsessively engineered sleep products – including mattresses, pillows, bedding, and furniture – designed in-house by the company's award-winning R&D team at Casper Labs. In addition to its e-commerce business, Casper owns and operates Sleep Shops across North America and its products are available at a growing list of retailers. For more information, visit the company's website at

Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX)

Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG) and other neurological and neuromuscular disorders. Catalyst's new drug application for Firdapse® (amifampridine) 10 mg tablets for the treatment of adults with LEMS was approved in 2018 by the U.S. Food & Drug Administration ("FDA"), and Firdapse is now commercially available in the United States. Further, Canada's national healthcare regulatory agency, Health Canada, recently approved the use of Firdapse® (amifampridine) for the treatment of patients in Canada with LEMS. Firdapse is currently being evaluated in clinical trials for the treatment of MuSK-MG and has received Orphan Drug Designation from the FDA for myasthenia gravis. For more information, visit the company's website at

cbdMD Inc. (NYSE American: YCBD)

cbdMD Inc. (NYSE American: YCBD) is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of "Team cbdMD." The company's comprehensive line includes over 100 SKUs of U.S. produced, non-THC1 CBD products. For more information, visit the company's website at

CECO Environmental Corp. (NASDAQ: CECE)

CECO Environmental Corp. (NASDAQ: CECE) is a global leader in air quality and fluid handling serving the energy, industrial and other niche markets. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean and more efficient solutions that help protect our shared environment. In regions around the world, CECO works to improve air quality, optimize the energy value chain and provide custom engineered solutions for applications including oil and gas, power generation, water and wastewater, battery production, poly silicon fabrication, chemical and petrochemical processing along with a range of others. For more information, visit the company's website at

Celsion Corp. (NASDAQ: CLSN)

Celsion Corp. (NASDAQ: CLSN) is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The company's product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Celsion also has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies. Both are novel synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection. For more information, visit the company's website at

Cellectar Biosciences Inc. (NASDAQ: CLRB)

Cellectar Biosciences Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company, is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The company's core objective is to leverage its proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop PDCs that specifically target cancer cells, delivering improved efficacy and better safety as a result of fewer off-target effects. The company's PDC platform possesses the potential for the discovery and development of the next-generation of cancer-targeting treatments, and it plans to develop PDCs independently and through research and development collaborations. The company's product pipeline includes CLR 131, a small-molecule PDC designed to provide targeted delivery of iodine-131 (radioisotope), and proprietary preclinical PDC chemotherapeutic programs, one preclinical PDC chemotherapeutic program (CLR 1900) and multiple partnered PDC assets. For more information, visit the company's website at

Celmatix Inc.

Celmatix Inc. is a preclinical-stage women's health biotech focused uniquely on ovarian biology. With a lead "pipeline-in-a-pill" RSTK program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix's proprietary multi-omic ovarian health platform, the world's largest of its kind, is the foundation of the company's novel pipeline of first-in-class therapies. For more information, visit the company's website at

Celsius Holdings Inc. (NASDAQ: CELH)

Celsius Holdings Inc. (NASDAQ: CELH), is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CELSIUS® has five beverage lines that each offer proprietary, functional, healthy-energy formulas clinically proven to offer significant health benefits to its users. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. For more information, visit the company's website at

Century Casinos Inc. (NASDAQ: CNTY)

Century Casinos Inc. (NASDAQ: CNTY), a casino entertainment company, owns and operates two Century Casino & Hotels in Colorado and one in Edmonton, Alberta, Canada; two Century Casinos in Missouri and one in St. Albert, Alberta, Canada; the Mountaineer Casino, Racetrack & Resort in West Virginia; the Century Mile Racetrack and Casino ("CMR") in Edmonton, Alberta, Canada; and Century Bets! Inc. ("CBS"). Through its Austrian subsidiary, Century Resorts Management GmbH ("CRM"), the company holds a 66.6% ownership interest in Casinos Poland Ltd and a 75% ownership interest in Century Downs Racetrack and Casino in Calgary, Alberta, Canada. The company operates four ship-based casinos. The company, through CRM, also owns a 7.5% interest in, and provides consulting services to Mendoza Central Entretenimientos S.A. For more information, visit the company's website at


CEVA Inc. (NASDAQ: CEVA) is the leading licensor of wireless connectivity and smart sensing technologies, offering Digital Signal Processors, AI processors, wireless platforms and complementary software for sensor fusion, image enhancement, computer vision, voice input and artificial intelligence. CEVA partners with semiconductor companies and OEMs worldwide to create power-efficient, intelligent and connected devices for a range of end markets, including mobile, consumer, automotive, robotics, industrial and IoT. For more information, visit the company's website at

Champions Oncology Inc. (NASDAQ: CSBR)

Champions Oncology Inc. (NASDAQ: CSBR) is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based discovery platforms, unique oncology software solutions, and innovative and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. For more information, visit the company's website at

Charge Enterprises Inc. (OTC: CRGE)

Charge Enterprises Inc. (OTC: CRGE) is a portfolio of global businesses with the vision of connecting people everywhere with communications, infrastructure and charging. With two distinct divisions, Charge Communications and Charge Infrastructure, the company's strategy is to do the unglamorous part of connecting phone calls and powering the future of movement. Charge Enterprises operates its current business through a number of subsidiaries, which it has recently acquired and/or formed. For more information, visit the company's website at

ChargePoint Inc. (NYSE: CHPT)

ChargePoint Inc. (NYSE: CHPT) is creating the new fueling network to move all people and goods on electricity. Since 2007, ChargePoint has been committed to making it easy for businesses and drivers to go electric with one of the largest EV charging networks and most complete portfolio of charging solutions available today. ChargePoint's cloud subscription platform and software-defined charging hardware are designed to include options for every charging scenario, from home and multifamily to workplace, parking, hospitality, retail and transport fleets of all types. Today, one ChargePoint account provides access to hundreds-of-thousands of places to charge in North America and Europe. To date, more than 88 million charging sessions have been delivered, with drivers plugging into the ChargePoint network approximately every two seconds. For more information, visit the company's website at

Charles & Colvard, Ltd. (NASDAQ: CTHR)

Charles & Colvard, Ltd. (NASDAQ: CTHR) believes fine jewelry can be accessible, beautiful and conscientious. Charles & Colvard is the original pioneer of lab-created moissanite, a rare gemstone formed from silicon carbide. The Company brings revolutionary gemstones and jewelry to market through its pinnacle Forever One™ moissanite brand and its premium Caydia™ lab grown diamond brand. Consumers seek Charles & Colvard fashion, bridal and fine jewelry because of its exceptional quality, incredible value and shared beliefs in environmental and social responsibility. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park. For more information, visit the company's website at

Charlotte's Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF)

Charlotte's Web Holdings Inc. (TSX: CWEB) (OTCQX: CWBHF), a Certified B Corporation headquartered in Boulder, Colorado, is the market leader in the production and distribution of innovative hemp-derived cannabidiol ("CBD") wellness products under a family of brands which includes Charlotte's Web™, CBD Medic™, CBD Clinic™, and Harmony Hemp. The company's premium quality products start with proprietary hemp genetics that are 100% American farm grown and manufacture into whole plant hemp extracts containing a full spectrum of naturally occurring phytocannabinoids including CBD, CBC, CBG, terpenes, flavonoids and other beneficial hemp compounds. For more information, visit the company's website at

ChromaDex Corp. (NASDAQ: CDXC)

ChromaDex Corp. (NASDAQ: CDXC) is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN nicotinamide riboside, sold directly to consumers as TRU NIAGEN, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN is helping the world age better. For more information, visit the company's website at

Clarus Corp. (NASDAQ: CLAR)

Clarus Corp. (NASDAQ: CLAR) is a leading developer, manufacturer and distributor of best-in class outdoor equipment and lifestyle products focused on the climb, ski, mountain, and sport markets. With a strong reputation for innovation, style, quality, design, safety and durability, Clarus' portfolio of iconic brands includes Black Diamond, Sierra, Barnes, PIEPS and SKINourishment. Clarus' brands are sold through specialty and online retailers, distributors and original equipment manufacturers throughout the U.S. and internationally. For more information, visit the company's website at

Clearside Biomedical Inc. (NASDAQ: CLSD)

Clearside Biomedical Inc. (NASDAQ: CLSD) is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside's proprietary SCS Microinjector® targets the suprachoroidal space (SCS®) and offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. Clearside's SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations such as gene therapy. For more information, visit the company's website at

Clene Inc. (NASDAQ: CLNN)

Clene Inc. (NASDAQ: CLNN), a clinical-stage biopharmaceutical company focused on neurodegenerative disease, has innovated a novel nanotherapeutics platform to create a new class of drugs—bioenergetic nanocatalysts. Clene's lead drug candidate, CNM-Au8, is a the concentrated nanocrystalline gold (Au) suspension that drives critical cellular bioenergetic reactions in the CNS. CNM-Au8 increases cellular energy to accelerate neurorepair and improve neuroprotection. Currently, CNM-Au8 is being investigated for efficacy and safety in a Phase 3 registration trial for ALS and in Phase 2 trials for Multiple Sclerosis and Parkinson's Disease. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. The company is based in Salt Lake City, Utah with R&D and manufacturing operations in Maryland. For more information, visit the company's website at

Clever Leaves Holdings Inc. (NASDAQ: CLVR)

Clever Leaves Holdings Inc. (NASDAQ: CLVR) is a multi-national cannabis company with a mission to operate in compliance with federal and state laws and with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabinoid business. With operations and investments in Canada, Colombia, Germany, Portugal and the United States, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. For more information, visit the company's website at

Climate Change Crisis Real Impact I Acquisition Corp. (NYSE: CLII)

Climate Change Crisis Real Impact I Acquisition Corp. (NYSE: CLII) is a special purpose acquisition company with a definitive agreement to merge with EVgo, the nation's largest public fast charging network for electric vehicles, and the first to be powered by 100% renewable energy. With more than 800 fast charging locations in more than 67 metropolitan areas across 34 states, EVgo owns and operates the greatest number of public fast charging locations in the U.S. and serves more than 220,000 customers. Founded in 2010, EVgo leads the way on transportation electrification, partnering with automakers; fleet and rideshare operators; retail hosts such as hotels, shopping centers, gas stations and parking lot operators; and other stakeholders to deploy advanced charging technology to expand network availability and make it easier for all U.S. drivers to take advantage of the benefits of driving an EV. For more information, visit the company's website at

Cocrystal Pharma Inc. (NASDAQ: COCP)

Cocrystal Pharma Inc. (NASDAQ: COCP) is a clinical stage biotechnology company seeking to discover and develop novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The company employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. These technologies are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer. Cocrystal Pharma has identified promising preclinical and early clinical stage antiviral therapeutics that target the replication process of influenza virus, SARS-CoV-2 virus, hepatitis C virus and norovirus. For more information, visit the company's website at

Coffee Holding Co. Inc. (NASDAQ: JVA)

Coffee Holding Co. Inc. (NASDAQ: JVA) is a leading integrated wholesale coffee roaster and dealer in the United States and one of the few coffee companies that offers a broad array of coffee products across the entire spectrum of consumer tastes, preferences and price points. Coffee Holding has been a family-operated business for three generations and has remained profitable through varying cycles in the coffee industry and the economy. The company's private label and branded coffee products are sold throughout the United States, Canada and abroad to supermarkets, wholesalers and individually owned and multi-unit retail customers. For more information, visit the company's website at

CohBar Inc. (NASDAQ: CWBR)

CohBar Inc. (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and development of mitochondria-based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria-based therapeutics originate from the discovery by CohBar's founders of a novel group of naturally occurring peptide sequences within the mitochondrial genome, some of which have been shown to have the potential to regulate key processes in multiple systems and organs in the body. To date, the company has discovered more than 100 mitochondrial derived peptides and generated over 1,000 analogs. CohBar's efforts focus on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases associated with the underlying impact of mitochondrial dysfunction. For more information, visit the company's website at

Columbia Care Inc. (CSE: CCHW) (OTCQX: CCHWF)

Columbia Care Inc. (CSE: CCHW) (OTCQX: CCHWF) is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 18 U.S. jurisdictions and the EU. Columbia Care currently operates 100 facilities including 76 dispensaries and 24 cultivation and manufacturing facilities. Columbia Care is one of the original providers of medical cannabis in the United States, and continues to deliver an industry-leading, patient-centered medicinal cannabis operation that has quickly expanded into the adult use market as a premier operator. The company currently offers products spanning flower, edibles, oils, and tablets and manufactures popular brands including Amber and Platinum Label CBD. For more information, visit the company's website at

Compass Diversified Holdings (NYSE: CODI)

Compass Diversified Holdings (NYSE: CODI) owns and manages a diverse set of highly defensible North American middle market businesses. Leveraging its permanent capital base, long-term disciplined approach and actionable expertise, CODI maintains controlling ownership interests in each of its subsidiaries, maximizing its ability to impact long-term cash flow generation and value creation. The company provides both debt and equity capital for its subsidiaries, contributing to their financial and operating flexibility. For more information, visit the company's website at

Compass Therapeutics Inc. (OTCQB: CMPX)

Compass Therapeutics Inc. (OTCQB: CMPX) is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. Compass is leveraging its proprietary StitchMabs™ and common light-chain based multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. The company's lead product candidate, CTX-471, is a fully human agonistic antibody of CD137 and is currently being evaluated in a Phase 1b study. The company's offices and labs are located in Boston, Massachusetts. For more information, visit the company's website at

Consolidated Water Co. Ltd. (NASDAQ: CWCO)

Consolidated Water Co. Ltd. (NASDAQ: CWCO) develops and operates advanced water supply and treatment plants and water distribution systems. The company operates water production facilities in the Cayman Islands, The Bahamas and the British Virgin Islands and operates water treatment facilities in the United States. The company also manufactures and services a wide range of products and provides design, engineering, management, operating and other services applicable to commercial and municipal water production, supply and treatment, and industrial water and wastewater treatment. For more information, visit the company's website at

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) is a clinical-stage company focused on the development and commercialization of novel medicines designed to target the endocannabinoid system. The company's lead product candidate, lenabasum, is a novel, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to provide an alternative to immunosuppressive medications in the treatment of chronic inflammatory and fibrotic diseases. Lenabasum is currently being evaluated in dermatomyositis and systemic lupus erythematosus. Corbus is also developing a pipeline of other preclinical drug candidates from its endocannabinoid system platform. For more information, visit the company's website at

CoreCivic Inc. (NYSE: CXW)

CoreCivic Inc. (NYSE: CXW) is a diversified government solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. CoreCivic provides a broad range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address America's recidivism crisis, and government real estate solutions. CoreCivic is the nation's largest owner of partnership correctional, detention and residential reentry facilities, and the company believes it is the largest private owner of real estate used by U.S. government agencies. The company has been a flexible and dependable partner for government for more than 35 years. For more information, visit the company's website at

Corvus Pharmaceuticals Inc. (NASDAQ: CRVS)

Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) is a clinical-stage biopharmaceutical company. Corvus' lead product candidate is CPI-006, a humanized monoclonal antibody directed against CD73 that has exhibited immunomodulatory activity and activation of immune cells in preclinical studies. CPI-006 is being evaluated in a Phase 3 clinical trial for the treatment of hospitalized patients with COVID-19 and in a multicenter Phase 1/1b oncology clinical trial as a single agent, in combination with ciforadenant and pembrolizumab. The company's second clinical program, CPI-818, is an investigational, oral, small molecule drug that selectively inhibited ITK in preclinical studies and is in a multicenter Phase 1/1b clinical trial in patients with several types of T-cell lymphomas. Its third clinical program, ciforadenant (CPI-444), is an oral, small molecule inhibitor of the A2A receptor. For more information, visit the company's website at

Crawford & Company (NYSE: CRD.A) (NYSE: CRD.B)

Crawford & Company (NYSE: CRD.A) (NYSE: CRD.B) is the world's largest publicly listed independent provider of claims management and outsourcing solutions to carriers, brokers and corporations with an expansive global network serving clients in more than 70 countries. The company's two classes of stock are substantially identical, except with respect to voting rights and the company's ability to pay greater cash dividends on the non-voting Class A Common Stock (CRD.A) than on the voting Class B Common Stock (CRD.B), subject to certain limitations. In addition, with respect to mergers or similar transactions, holders of CRD.A must receive the same type and amount of consideration as holders of CRD.B, unless different consideration is approved by the holders of 75 percent of CRD.A, voting as a class. More information is available at

Cree Inc. (NASDAQ: CREE)

Cree Inc. (NASDAQ: CREE) has served as the global leader in silicon carbide technology and production for more than 30 years, leading the worldwide transition from silicon to silicon carbide. Customers leverage the Wolfspeed® product portfolio for disruptive technology solutions that support a more efficient, sustainable future, including electric vehicles, fast charging, 5G, power supplies, renewable energy and storage, as well as aerospace and defense. The company's team is dedicated to driving a significant shift in the technology sector and creating a global semiconductor powerhouse. For more information, visit the company's website at

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) is one of the largest vertically integrated, multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods ("CPG") approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands include some of the most recognized and trusted brands including Cresco, Remedi, High Supply, Cresco Reserve, Good News, Wonder Wellness, FloraCal Farms and Mindy's Chef Led Artisanal Edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside, Cresco Labs' national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. For more information, visit the company's website at


CRISPR Therapeutics AG (NASDAQ: CRSP) is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California, and London, United Kingdom. For more information, visit the company's website at

Crown Electrokinetics Corp. (NASDAQ: CRKN)

Crown Electrokinetics Corp. (NASDAQ: CRKN) is a Corvallis-based startup with a novel approach to the growing smart glass industry. The company is a global leader in DynamicTint(TM). Originally invented by Hewlett-Packard, the company's technology allows any glass surface to transition between clear and dark in seconds. DynamicTint allows windows to transition from transparent to black. With applications for a wide array of windows, including commercial buildings, automotive sunroofs and residential skylights, Crown partners with leading glass and film manufacturers, licensing its intellectual property for mass production. At the core of Crown's technology is a thin film that is powered by electrically charged pigment, which not only replaces common window tints but is also a more sustainable alternative to traditional window treatments. For more information, visit the company's website at

Cryoport Inc. (NASDAQ: CYRX)

Cryoport Inc. (NASDAQ: CYRX) is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions and services serving the biopharma, reproductive medicine and animal health markets. Through its family of companies, Cryoport Systems, MVE Biological Solutions, CRYOPDP and CRYOGENE, Cryoport provides strategic solutions that support the growing needs of these markets. For more information, visit the company's website at

Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF)

Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) is a leading U.S. provider of consumer products in cannabis, with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a vertically integrated, high-growth cannabis operator known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 96 dispensaries, 23 cultivation sites and over 30 processing sites, and employs over 3,000 team members across the United States. For more information, visit the company's website at

CuriosityStream Inc. (NASDAQ: CURI)

CuriosityStream Inc. (NASDAQ: CURI) is a leading global factual streaming service and media company. CuriosityStream's documentary series and features cover every topic from space exploration to adventure to the secret life of pets, empowering viewers of all ages to fuel their passions and explore new ones. With thousands of titles, many in Ultra HD 4K, including exclusive originals, CuriosityStream features stunning visuals and unrivaled storytelling to demystify science, nature, history, technology, society and lifestyle. CuriosityStream reaches over 13 million subscribers and is available worldwide to watch on TV, desktop, mobile and tablets. For more information, visit the company's website at

Curis Inc. (NASDAQ: CRIS)

Curis Inc. (NASDAQ: CRIS) is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including the VISTA/PDL1 antagonist CA-170, and the TIM3/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently undergoing testing in a Phase 1 trial in patients with non-Hodgkin's lymphoma, both as a monotherapy and in combination with BTK inhibitor, ibrutinib. Curis is also evaluating CA-4948 in a Phase 1 trial in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, Curis is engaged in a collaboration with ImmuNext for development of CI-8993, a monoclonal anti-VISTA antibody, which is currently undergoing testing in a Phase 1a/1b trial in patients with solid tumors. For more information, visit the company's website at

Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC)

Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, in solid tumors and hematological malignancies. The anti-mitotic program is evaluating CYC140, a PLK1 inhibitor, in advanced cancers. Cyclacel's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For more information, visit the company's website at

CytRx Corp. (OTCQB: CYTR)

CytRx Corp. (OTCQB: CYTR) is a biopharmaceutical company with expertise in discovering and developing new therapeutics principally to treat patients with cancer and neurodegenerative diseases. CytRx's most advanced drug conjugate, aldoxorubicin, is an improved version of the widely used anticancer drug doxorubicin and has been out-licensed to ImmunityBio, Inc. In addition, CytRx's other drug candidate, arimoclomol, was sold to Orphazyme in exchange for milestone payments and royalties. Orphazyme is testing arimoclomol in four indications including amyotrophic lateral sclerosis (ALS), Niemann-Pick disease Type C (NPC), Gaucher disease and sporadic Inclusion Body Myositis (sIBM) and have filed an NDA for NPC with a PDUFA date of June 17, 2021. For more information, visit the company's website at

Daqo New Energy Corp. (NYSE: DQ)

Daqo New Energy Corp. (NYSE: DQ) is a leading manufacturer of high-purity polysilicon for the global solar PV industry. Founded in 2007, the company is one of the world's lowest cost producers of high-purity polysilicon. Daqo's highly efficient and technically advanced manufacturing facility in China currently has a nameplate annual polysilicon production capacity of 70,000 metric tons. For more information, visit the company's website at

Daré Bioscience Inc. (NASDAQ: DARE)

Daré Bioscience Inc. (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. The company's mission is to identify, develop and bring to market a diverse portfolio of differentiated therapies that expand treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health, and fertility. Daré's product portfolio includes potential first-in-category candidates in clinical development: Ovaprene®, a hormone-free, monthly contraceptive intravaginal ring whose U.S. commercial rights are under a license agreement with Bayer; Sildenafil Cream, 3.6%, a novel cream formulation of sildenafil to treat female sexual arousal disorder utilizing the active ingredient in Viagra; DARE-BV1, a unique hydrogel formulation of clindamycin phosphate 2% to treat bacterial vaginosis via a single application; and DARE-HRT1, a combination bio-identical estradiol and progesterone intravaginal ring for hormone replacement therapy following menopause. For more information, visit the company's website at

Darling Ingredients Inc. (NYSE: DAR)

Darling Ingredients Inc. (NYSE: DAR) is one of the world's leading producers of organic ingredients, producing a wide array of sustainable protein and fat products while being one of the largest producers of renewable clean energy. With operations on five continents, Darling collects waste streams from the agri-food industry, repurposing into specialty ingredients, such as hydrolyzed collagen, edible and feed-grade fats, animal proteins and meals, plasma, pet food ingredients, fuel feedstocks, and green bioenergy. Darling is a 50% joint venture partner in Diamond Green Diesel (DGD), North America's largest renewable diesel manufacturer, currently producing approximately 290 million gallons of renewable diesel annually. For more information, visit the company's website at

Delcath Systems Inc. (NASDAQ: DCTH)

Delcath Systems Inc. (NASDAQ: DCTH) is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company's investigational product, melphalan hydrochloride for injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS), is designed to administer high-dose chemotherapy to the liver while minimizing systemic exposure and associated side effects. In addition to the Phase 3 FOCUS trial, the company has initiated a global Phase 3 clinical trial for intrahepatic cholangiocarcinoma (ICC) called 'The ALIGN Trial'. Delcath is also evaluating other forms of metastatic liver cancers. For more information, visit the company's website at

Denbury Inc. (NYSE: DEN)

Denbury Inc. (NYSE: DEN) is an independent energy company with operations focused on producing oil from mature oil fields in the Gulf Coast and Rocky Mountain regions. The Company is differentiated by its focus on CO2 Enhanced Oil Recovery (EOR) and the emerging Carbon Capture, Use, and Storage (CCUS) industry, supported by the Company's CO2 EOR technical and operational expertise and its extensive CO2 pipeline infrastructure. The utilization of captured industrial-sourced CO2 in EOR significantly reduces the carbon footprint of the oil that Denbury produces, underpinning the Company's goal to fully offset its Scope 1, 2, and 3 CO2 emissions within the decade. For more information about Denbury, please visit

Delta Apparel Inc. (NYSE American: DLA)

Delta Apparel Inc. (NYSE American: DLA), along with operating subsidiaries DTG2Go LLC, Salt Life LLC, and M.J. Soffe LLC, is a vertically integrated, international apparel company that designs, manufactures, sources and markets a diverse portfolio of core activewear and lifestyle apparel products under the primary brands of Salt Life®, COAST®, Soffe® and Delta. The company is a market leader in the on-demand, digital print and fulfillment industry, bringing DTG2Go's proprietary technology and innovation to the supply chain of its customers. The company specializes in selling casual and athletic products through a variety of distribution channels and tiers, including outdoor and sporting goods retailers, independent and specialty stores, better department stores and mid-tier retailers, mass merchants and e-retailers and the U.S. military, as well as through its business-to-business digital platform. For more information, visit the company's website at

DiaMedica Therapeutics Inc. (NADAQ: DMAC)

DiaMedica Therapeutics Inc. (NADAQ: DMAC) is a clinical-stage biopharmaceutical company developing novel recombinant (synthetic) proteins. The company is using its patented and licensed technologies to establish DiaMedica Therapeutics as a leader in the development and commercialization of novel recombinant proteins to treat kidney and neurological diseases. The primary focus is on chronic kidney disease ("CKD") and acute ischemic stroke ("AIS"). The company is advancing its lead drug candidate, DM199, through clinical trials, as appropriate, to create shareholder value by establishing its clinical and commercial potential as a therapy for AIS and CKD. For more information, visit the company's website at

Digi International Inc. (NASDAQ: DGII)

Digi International Inc. (NASDAQ: DGII) is a leading global provider of IoT connectivity products, services and solutions. The company helps customers create next-generation connected products and deploy and manage critical communications infrastructures in demanding environments with high levels of security and reliability. Founded in 1985, Digi has helped customers connect over 100 million things and growing. For more information, visit the company's website at

Digital Turbine Inc. (NASDAQ: APPS)

Digital Turbine Inc. (NASDAQ: APPS) simplifies content discovery and delivers it directly to the device. Its on-device media platform powers frictionless app and content discovery, user acquisition and engagement, operational efficiency and monetization opportunities. Digital Turbine's technology platform has been adopted by more than 40 mobile operators and OEMs and has delivered more than three billion app preloads for tens of thousands advertising campaigns. The company is headquartered in Austin, Texas, with global offices in Arlington, Durham, Mumbai, San Francisco, Singapore and Tel Aviv. For more information, visit the company's website at

DMC Global Inc. (NASDAQ: BOOM)

DMC Global Inc. (NASDAQ: BOOM) serves a global network of customers in the energy, infrastructure and industrials markets through two core businesses: NobelClad and Oilfield Products. The NobelClad segment is the world's largest manufacturer of explosion-welded clad metal plates, which are used to fabricate capital equipment utilized within various process industries and other industrial sectors. Oilfield Products refers to the business of DynaEnergetics, an international developer, manufacturer and marketer of advanced explosive components and systems used to perforate oil and gas wells. For more information, visit the company's website at

DMG Blockchain Solutions Inc. (TSX.V: DMGI) (OTCQB: DMGGF)

DMG Blockchain Solutions Inc. (TSX.V: DMGI) (OTCQB: DMGGF) is a diversified cryptocurrency and blockchain platform company that is focused on the two primary opportunities in the sector – mining public blockchains and applying permissioned blockchain technology. DMG focuses on mining bitcoin, providing hosting services for industrial mining clients, earning revenues from block rewards and transaction fees, developing data analytics and forensic software products, working with auditors, law firms, and law enforcement to provide technical expertise, DMG's permissioned blockchain technology is focused on developing enterprise software for the supply chain management of controlled products. DMG's strategy is to become the domain experts across the business verticals it focuses on. For more information, visit the company's website at

Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF)

Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) is the creator of quality, cutting-edge software and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money and lives. For more information, visit the company's website at

Drive Shack Inc. (NYSE: DS)

Drive Shack Inc. (NYSE: DS) is a leading owner and operator of golf-related leisure and entertainment businesses. Today, the company's portfolio consists of Drive Shack, which is developing a nationwide network of innovative golf entertainment venues; American Golf, one of the largest golf course businesses in the world; and various real estate-related assets. For more information, visit the company's website at


DSP Group Inc. (NASDAQ: DSPG) is a leading global provider of wireless chipset solutions for converged communications. Delivering semiconductor system solutions with software and hardware reference designs, DSP Group enables OEMs/ODMs, consumer electronics (CE) manufacturers and service providers to cost-effectively develop new revenue-generating products with fast time to market. DSP Group provides a broad portfolio of wireless chipsets integrating DECT/CAT-iq, ULE, Wi-Fi, PSTN, HDClear, video and VoIP technologies. DSP Group enables converged voice, audio, video and data connectivity across diverse mobile, consumer and enterprise products – from mobile devices, connected multimedia screens, and home automation & security to cordless phones, VoIP systems, and home gateways. For more information, visit the company's website at


DURECT Corp. (NASDAQ: DRRX) is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program. DUR-928, the company's lead drug candidate is in clinical development for the potential treatment of alcohol-associated hepatitis (AH) for which FDA has granted a Fast-Track Designation, COVID-19 patients, and non-alcoholic steatohepatitis (NASH). DURECT's proprietary drug delivery technologies are designed to enable new indications and enhanced attributes for small-molecule and biologic drugs. POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the innovative SABER platform technology, is now FDA-approved. For more information, visit the company's website at

Dyadic International Inc. (NASDAQ: DYAI)

Dyadic International Inc. (NASDAQ: DYAI) is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical protein production platform based on the fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila), named C1. The C1 microorganism, which enables the development and large-scale manufacture of low-cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs. For more information, visit the company's website at

Dynatronics Corp. (NASDAQ: DYNT)

Dynatronics Corp. (NASDAQ: DYNT) is a leading medical device company committed to providing high-quality restorative products designed to accelerate achieving optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company products are marketed under a portfolio of high-quality, well-known industry brands including Bird & Cronin, Dynatron Solaris, Hausmann, Physician's Choice, and PROTEAM, among others. Dynatronics has built a solid reputation over the past three decades for quality, excellent customer service, and unmatched clinical support. For more information, visit the company's website at

Earthstone Energy Inc. (NYSE: ESTE)

Earthstone Energy Inc. (NYSE: ESTE) is a growth-oriented, independent energy company engaged in the development and operation of oil and natural gas properties. The company focus on growth is aimed at discovering new sources of oil and natural gas reserves, acquiring strategically significant properties and boosting cash flows from existing oil and gas production. Its primary assets are located in the Midland Basin of west Texas and the Eagle Ford Trend of south Texas. For more information, visit the company's website at

Eastside Distilling Inc. (NASDAQ: EAST)

Eastside Distilling Inc. (NASDAQ: EAST) has been producing high-quality, award-winning craft spirits in Portland, Oregon, since 2008. The company is distinguished by its highly decorated product lineup that includes Azuñia Tequilas, Burnside Whiskeys, Hue-Hue Coffee Rum, and Portland Potato Vodkas. All Eastside spirits are crafted from natural ingredients for quality and taste. Eastside's Craft Canning + Bottling subsidiary is one of the Northwest's leading independent ready-to-drink canners. For more information, visit the company's website at

eGain Corp. (NASDAQ: EGAN)

eGain Corp. (NASDAQ: EGAN) is a leading provider of omnichannel customer engagement solutions. eGain customer engagement solutions deliver digital transformation for leading brands–powered by virtual assistance, AI, knowledge, and analytics. The company's comprehensive suite of applications help clients deliver memorable, digital-first customer experiences in an omnichannel world. For more information, visit the company's website at

Electrovaya Inc. (TSX: EFL) (OTCQB: EFLVF)

Electrovaya Inc. (TSX: EFL) (OTCQB: EFLVF) designs, develops and manufactures proprietary Lithium-Ion batteries, battery systems and battery-related products for energy storage, clean electric transportation and other specialized applications. Electrovaya is a technology focused company with extensive IP. Headquartered in Ontario, Canada, Electrovaya has production facilities in Canada, with customers around the globe. For more information, visit the company's website at

Enanta Pharmaceuticals Inc. (NASDAQ: ENTA)

Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. Enanta's research and development efforts have produced clinical candidates for the following disease targets: respiratory syncytial virus (RSV), hepatitis B virus (HBV) and non-alcoholic steatohepatitis (NASH). Enanta is also conducting research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). Enanta's research and development activities are funded by royalties from hepatitis C virus (HCV) products developed under its collaboration with AbbVie. For more information, visit the company's website at

Endeavour Silver Corp. (TSX: EDR) (NYSE: EXK)

Endeavour Silver Corp. (TSX: EDR) (NYSE: EXK) is a mid-tier precious metals mining company that owns and operates three high-grade, underground, silver-gold mines in Mexico. Endeavour is currently advancing the Terronera mine project towards a development decision and exploring its portfolio of exploration and development projects in Mexico and Chile to facilitate its goal to become a premier senior silver producer. Endeavor's philosophy of corporate social integrity creates value for all stakeholders. For more information, visit the company's website at

ENDRA Life Sciences Inc. (NASDAQ: NDRA)

ENDRA Life Sciences Inc. (NASDAQ: NDRA) is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology that mirrors some applications similar to CT or MRI, but at 50X lower cost, at the point of patient care. TAEUS is designed to work in concert with one million ultrasound systems in global use today. TAEUS is initially focused on the measurement of fat in the liver, as a means to assess and monitor NAFLD and NASH, chronic liver conditions that affect over 1 billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. For more information, visit the company's website at

Energous Corp. (NASDAQ: WATT)

Energous Corp. (NASDAQ: WATT) is leading the next generation of wireless charging – wireless charging 2.0 – with its award-winning WattUp technology, which supports fast, efficient contact-based charging, as well as charging at a distance. WattUp is a scalable, RF-based wireless charging technology that offers substantial improvements in contact-based charging efficiency, foreign object detection, orientation freedom and thermal performance compared to older, coil-based charging technologies. Energous received the world's first FCC Part 18 certification for at-a-distance wireless charging, and the company has 227 awarded patents for its WattUp wireless charging technology to-date. For more information, visit the company's website at

Enphase Energy Inc. (NASDAQ: ENPH)

Enphase Energy Inc. (NASDAQ: ENPH), a global energy technology company, delivers smart, easy-to-use solutions that manage solar generation, storage and communication on one intelligent platform. The company revolutionized the solar industry with its microinverter technology and produces a fully integrated solar-plus-storage solution. Enphase has shipped more than 30 million microinverters, and approximately 1.3 million Enphase-based systems have been deployed in more than 130 countries. For more information, visit the company's website at

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX)

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis' pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae infections), ETX0282CPDP (targeting Enterobacteriaceae infections) and ETX0462 (targeting Pseudomonas infections). For more information, visit the company's website at

EnviroLeach Technologies Inc. (CSE: ETI) (OTCQB: EVLLF)

EnviroLeach Technologies Inc. (CSE: ETI) (OTCQB: EVLLF) is engaged in the development and commercialization of environmentally friendly formulas and technologies for the treatment of materials in the mining and recycling sectors. Using its proprietary non-cyanide, water-based, neutral pH treatment process, EnviroLeach extracts precious metals from ores, concentrates and e-waste using only FDA-approved additives and ambient temperature water. Backed by the momentum of a first-class staff of scientists and engineers, tens of thousands of individual assays, independent validations, strategic partners and over $20 million in research and development, EnviroLeach's technology is emerging as a potential new standard for the provision of eco-friendly methods for the hydrometallurgical extraction of precious metals in both the conventional mining and e-waste sectors. For more information, visit the company's website at

Escalade Inc. (NASDAQ: ESCA)

Escalade Inc. (NASDAQ: ESCA) is a global manufacturer and distributor of sports and outdoor recreational equipment. Leaders in their respective categories, Escalade Sports' brands include Bear Archery, Bear X, Trophy Ridge, Rocket, SIK and Cajun Bowfishing archery equipment; STIGA and Ping-Pong table tennis; Accudart and Unicorn darting; RAVE Sports water recreation products; Atomic, Victory Tailgate, Triumph Sports, Viva Sol and Zume Games recreational games; DURA and Onix pickleball equipment; Goalrilla, Goalsetter residential in-ground basketball systems; Goaliath and Silverback residential in-ground and portable basketball goals; Lifeline® and the STEP® fitness products; Woodplay® premium playsets; American Heritage Billiards premium billiards and game room assortment; and Cue&Case, a leader in specialty billiard accessories. Escalade Sports' products are available at sporting goods dealers and independent retailers nationwide. For more information, visit the company's website at

Esports Entertainment Group Inc. (NASDAQ: GMBL)

Esports Entertainment Group Inc. (NASDAQ: GMBL) is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange-style wagering on esports events through a licensed, regulated and secure platform to the global esports audience. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multiplayer mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and video game industries, as well as esports. The company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The company maintains offices in Malta. For more information, visit the company's website at

Etsy Inc. (NASDAQ: ETSY)

Etsy Inc. (NASDAQ: ETSY) operates two-sided online marketplaces that connect millions of passionate and creative buyers and sellers around the world. The company's primary marketplace,, is the global destination for unique and creative goods. Buyers come to Etsy to be inspired and delighted by items that are crafted and curated by creative entrepreneurs. For sellers, Etsy offers a range of tools and services that address key business needs. In addition, Etsy Inc. owns Reverb, a leading global online marketplace dedicated to buying and selling new, used, and vintage musical instruments. Etsy's mission is to keep commerce human and is committed to using the power of business to strengthen communities and empower people. For more information, visit the company's website at

Everi Holdings Inc. (NYSE: EVRI)

Everi Holdings Inc. (NYSE: EVRI) is a leading supplier of imaginative entertainment and trusted technology solutions for the casino and digital gaming industry. Everi's mission is to transform the casino floor through innovative gaming and financial technology and loyalty solutions. With a focus on both land-based and digital gaming operators and players, the company develops entertaining games and gaming machines, gaming systems and services that facilitate memorable player experiences, and is a preeminent and comprehensive provider of financial products and services that offer convenient and secure cash and cashless-based financial transactions, self-service player loyalty tools and applications, and intelligence software and other intuitive solutions that improve casino operational efficiencies and fulfill regulatory compliance requirements. For more information, visit the company's website at

EVI Industries Inc. (NYSE American: EVI)

EVI Industries Inc. (NYSE American: EVI) is a distributor of commercial laundry and dry-cleaning equipment, industrial boilers, and related parts, supplies, and technical services. The company has been involved in this industry since 1959 and is the only publicly traded distributor in this industry. EVI Industries seeks to grow its North American market share through the execution of its buy-and-build strategy. In that pursuit, EVI Industries intends to focus on buying market-leading laundry and general cleaning products businesses and building them through the implementation of a growth culture that focuses on adding new locations, offering a more expansive and complimentary product line, and delivering a vast array of technical services. For more information, visit the company's website at

Evolution Petroleum Corp. Inc. (NYSE American: EPM)

Evolution Petroleum Corp. Inc. (NYSE American: EPM) is an oil company focused on delivering a sustainable dividend yield to its shareholders through the ownership, management, and development of producing oil and gas properties. The company's long-term goal is to build a diversified portfolio of oil and gas assets primarily through acquisition, while seeking opportunities to maintain and increase production through selective development, production enhancement and other exploitation efforts on its properties. Evolution's largest assets is its interests in a CO2 enhanced oil recovery project in Louisiana's Delhi field and its interests in a secondary recovery project in Wyoming's Hamilton Dome field. For more information, visit the company's website at

Eyenovia Inc. (NASDAQ: EYEN)

Eyenovia Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more information, visit the company's website at

Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF)

Exro Technologies Inc. (TSX.V: EXRO) (OTCQB: EXROF) is a clean tech company that has developed a new class of control technology for electric powertrains. Exro's advanced motor control technology – its 'Coil Driver' – expands the capabilities of electric motors and powertrains. The Coil Driver enables two separate torque profiles within a given motor. The first is calibrated for low speed and high torque, while the second provides expanded operation at high speed. The ability to change configuration allows efficiency optimization for each operating mode, resulting in overall reductions in energy consumption. The controller automatically and seamlessly selects the appropriate configuration in real time so that torque demand and efficiency are optimized. Implementation of Exro's technology can yield the following results: increased drive cycle efficiency, reduced system volume, reduced weight, expanded torque and enhanced speed capabilities. For more information, visit the company's website at

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717